Skip to main content
Clinical Trials/NCT03481348
NCT03481348
Completed
Phase 1

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis: A Pilot Study With 20 Patients

University of Ulm1 site in 1 country20 target enrollmentFebruary 1, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Amyotrophic Lateral Sclerosis
Sponsor
University of Ulm
Enrollment
20
Locations
1
Primary Endpoint
Penetration Aspiration Scale (PAS) Score
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

During the course of ALS most patients develop swallowing deficits. In this pilot study we investigate if dysphagia in ALS can be improved by Pharyngeal Electrical Stimulation (PES). PES is Communauté Européenne (CE-) certificated and has been approved for treatment of neurological, oropharyngeal dysphagia. During PES, electrical stimuli are applied at the pharynx via a nasogastral tube with the aim of triggering reorganization processes in damaged brain structures. There is evidence of a positive effect of PES in Stroke and Multiple Sclerosis patients.

Registry
clinicaltrials.gov
Start Date
February 1, 2018
End Date
July 21, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Ulm
Responsible Party
Principal Investigator
Principal Investigator

Albert Christian Ludolph, Prof.

Prof.

University of Ulm

Eligibility Criteria

Inclusion Criteria

  • possible, probable or definite ALS according to the revised El Escorial criteria (Brooks et al. 2000)
  • age \>18 years
  • able to understand all information and to give full consent according to good clinical practice (GCP)
  • moderate ot severe dysphagia, defined by a mean value (all consistencies) of 4

Exclusion Criteria

  • concurrent participation in another interventional trial
  • tracheostomy
  • severe psychiatric disorder or clinically manifest dementia
  • pulmonal or cardial disorder which constitutes a risk when inserting the tube into the pharynx
  • permanent cardiac pacemaker or defibrillator

Outcomes

Primary Outcomes

Penetration Aspiration Scale (PAS) Score

Time Frame: day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Degree of Penetration and Aspiration evaluated by fiberendoscopic evaluation of swallowing (FEES)

Secondary Outcomes

  • Swallowing-Quality of Life Score (SWAL-QOL)(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)
  • Functional Oral Intake Scale (FOIS) Score(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)
  • Schluckbeeinträchtigungs-Skala (SBS) Score(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)
  • Dysphagia Severity Rating Scale (DSRS) Score(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)
  • Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALS-FRS-R)(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)
  • Frequency of Adverse Events(day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90)

Study Sites (1)

Loading locations...

Similar Trials